MarketInOut Stock Screener Log In | Sign Up

TriSalus Life Sciences Inc Wt

NASDAQ • Healthcare • Medical Devices • Quote as of 10/28/2026 15:48
TriSalus Life Sciences Inc Wt stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Earnings Date11/13/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.9
Likely reliable

Relative Strength

95 / 100
Top performer

Debt / Equity

5.26
Extremely leveraged

Pre-Tax Margin

-63%
Severely loss-making

Altman Z-Score

-4.3
Deeply distressed

Business Description

TriSalus Life Sciences is a US-based medical company focused on improving treatment options for patients with liver and pancreatic cancers, which are among the hardest cancers to treat effectively. The company has developed specialized delivery systems that use controlled pressure to get cancer-fighting drugs directly to tumors, and these tools are already being used by doctors in clinical settings. TriSalus is also running early-stage trials on a new immune-based therapy called nelitolimod, which aims to help the body fight several types of liver and pancreatic cancers. Founded in 2009 and based in Westminster, Colorado, the company works closely with a range of medical professionals to bring its technology into everyday patient care.

Key Fundamentals

RPS0.90
ROIC-521
ROA-57.22
EBITDA, mln-29.95
Revenue, mln45.08

Quote Details

Last 0.9424
Change 0.1924 (25.65%)
Open 0.65
Volume 5,396
Turnover 5,085.19
Average Volume 3,685.62

Financial Ratios

Pre-Tax Profit Margin-63
Current Ratio5.35
Price / Book8.22
Debt / Equity5.26
Price / Sales3.81

Financial Strength

Altman Z-Score-4.3
Piotroski F-Score 5 / 9
Beneish M-Score-2.9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -3.83% 19 / 100   
1 Month 68.29% 99 / 100   
2 Months 17.8% 90 / 100   
6 Months -35.01% 17 / 100   
1 Year -49.33% 19 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog